Clever Leaves Holdings Inc. (CLVR): Price and Financial Metrics

Clever Leaves Holdings Inc. (CLVR): $10.85

0.08 (+0.74%)

POWR Rating

Component Grades













Add CLVR to Watchlist
Sign Up

Industry: Agriculture


of 30

in industry

CLVR Stock Price Chart Interactive Chart >

Price chart for CLVR

CLVR Price/Volume Stats

Current price $10.85 52-week high $19.46
Prev. close $10.77 52-week low $7.95
Day low $10.44 Volume 164,400
Day high $10.89 Avg. volume 866,801
50-day MA $10.24 Dividend yield N/A
200-day MA $0.00 Market Cap 283.68M

Clever Leaves Holdings Inc. (CLVR) Company Bio

Clever Leaves Holdings, Inc. operates as a holding company. It produces pharmaceutical-grade cannabinoids. The company was founded on July 23, 2020 and is headquartered in New York, NY.

CLVR Latest News Stream

Event/Time News Detail
Loading, please wait...

CLVR Latest Social Stream

Loading social stream, please wait...

View Full CLVR Social Stream

Latest CLVR News From Around the Web

Below are the latest news stories about Clever Leaves Holdings Inc that investors may wish to consider to help them evaluate CLVR as an investment opportunity.

Clever Leaves Announces Entry into Mexican Market Through Partnership with CBD Life

The partnership positions both companies to become leaders in the Mexican medical cannabis industry.NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced it has entered into an active pharmaceutical ingredient (“API”) supply agreement with CBD Life Holding SAPI de CV (“CBD Life”), an emerging leader in the Mexican canna

Yahoo | June 16, 2021

Clever Leaves to Join Russell Microcap Index in June 2021

NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a multinational operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, announced that it is set to join the Russell Microcap® Index, effective at market open in the United States on June 28, 2021, upon the conclusion of the Russell indexes’ annual reconstitution. The decision was first disclosed in a preliminary list of additions published by the FTSE

Yahoo | June 14, 2021

PharmaCielo CEO Henning von Koss - Colombian Grown Pharmaceutical Cannabis (Video)

PharmaCielo (PCLOF) is focused on sustainable processing and supplying of Colombian grown medical-grade cannabis products to large channel distributors. PharmaCielo received its Colombian manufacturing licence in 2016, Colombia being one of the first countries to legalize and regulate a national medical-cannabis industry (it's still not adult-use legal). Colombia is the...

CEO Interviews on Seeking Alpha | June 10, 2021

Clever Leaves to Present at the Benzinga Virtual Cannabis Capital Conference on June 3, 2021

NEW YORK, May 27, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a multinational operator, or MNO, and licensed producer of pharmaceutical-grade cannabinoids, has been invited to present at the Benzinga Cannabis Capital Conference, which is being held virtually from June 3-4, 2021. Clever Leaves management is scheduled to present on Thursday, June 3rd at 1:35 p.m. Eastern time, with one-on-one meetings to be held throughout the conference. The presentation will be webcast live and available for replay here and via the Events section of the Company’s website here. To receive additional information, request an invitation or schedule a one-on-one meeting with Clever Leaves management, please contact your Benzinga representative or th...

Yahoo | May 27, 2021

Clever Leaves Holdings Inc. 2021 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Clever Leaves Holdings Inc. in conjunction with their 2021 Q1 earnings call....

SA Transcripts on Seeking Alpha | May 19, 2021

Read More 'CLVR' Stories Here

CLVR Price Returns

1-mo 20.96%
3-mo -21.77%
6-mo -0.46%
1-year N/A
3-year N/A
5-year N/A
YTD 21.91%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6129 seconds.